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Received April 26, 2016; accepted July 15, 2016AbstractBackground: We aimed to evaluate the efficacy and safety of dinoprostone for cervical ripening and labor induction in patients with term
oligohydramnios and Bishop score  5.
Methods: This was a prospective caseecontrol study, which included 104 consecutive women with a Bishop score 5. Participants were divided
into two groups. Women with term isolated oligohydramnios and Bishop score 5 underwent induction of labor with a vaginal insert containing
10-mg timed-release dinoprostone (prostaglandin E2; Group A, n¼ 40). The control group, Group B, consisted of 64 cases of pregnancy with
normal amniotic fluid volume (amniotic fluid index 5 cm) and Bishop score 5, and was matched for patient's age and parity. The primary
outcome was time from induction to delivery; the secondary outcomes were the caesarean section (CS) rate, uterine hyperstimulation, rate of
failed induction, and neonatal complications.
Results: The mean time interval from induction to delivery was not different between the two groups ( p¼ 0.849), but there was a statistically
significant difference between the groups in terms of the CS rate ( p¼ 0.005). There were no differences between the groups in neonatal outcome
or perinatal morbidity or mortality.
Conclusion: Dinoprostone appears to be a safe alternative for induction of labor in pregnancies with oligohydramnios. Induction of labor with
dinoprostone in term pregnancies with isolated oligohydramnios is associated with increased rate of CS but there is no higher risk of perinatal
complications.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Oligohydramnios complicates 0.5e5% of all pregnancies.
The prevalence of oligohydramnios depends largely on the
definition and criteria used for distinguishing it from others.1Conflicts of interest: The authors declare that they have no conflicts of interest
related to the subject matter or materials discussed in this article.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The common etiological factors associated with oligohy-
dramnios are ruptured membranes, congenital abnormalities,
and placental insufficiency. It is thought to be associated with
increased maternal and fetal morbidities. The perinatal
morbidity and mortality are due to a high risk of caesarean
deliveries owing to fetal distress, low Apgar scores, and
meconium aspiration syndrome in the fetus.2
Fluid volume is a biophysical parameter with particular
significance in high-risk pregnancies, as it provides valuable
information about fetal well-being and for decision-making for
induction of labor. Because oligohydramnios has been
circumstantially associated with a variety of poor pregnancyn of labor and cervical ripening for term isolated oligohydramnios in pregnant
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of labor in pregnancies complicated by decreased amniotic
fluid volume.3
The ideal method to induce labor should be safe, painless,
inexpensive, comfortable, and effective. However, such a
perfect method does not exist at present. Most of the currently
available methods for labor induction try to mimic the phys-
iological sequence of cervical effacement and dilatation fol-
lowed by uterine contraction, but the majority achieve only
part of the natural progression. Oxytocin, misoprostol, and
dinoprostone are the most often used agents for cervical
ripening and labor induction.4
In this study, we aimed to compare the efficacy and safety
of dinoprostone for cervical ripening and labor induction in
term pregnancies with isolated oligohydriamnios.
2. Methods
This prospective study was conducted at the Zekai Tahir
Burak Woman's Health, Research and Education Hospital,
Ankara, Turkey between April 2009 and August 2009. The
study was approved by the local Ethics Committee of the
hospital, and an informed consent was signed by all patients
before treatment, as in all cases of labor induction at our
institution. Forty consecutive women with term isolated oli-
gohydramnios and Bishop score 5 underwent induction of
labor with a vaginal insert containing 10-mg timed-release
dinoprostone (prostaglandin E2; Group A). Oligohydramnios
was defined as an amniotic fluid index (AFI) of < 5 cm.2 The
control group, Group B, consisted of 64 cases of pregnancy
with normal amniotic fluid volume (AFI  5 cm) and Bishop
score 5, and was matched for patient's age and parity. The
criteria of inclusion were women with a singleton live cephalic
presentation between 37 weeks and 42 weeks, intact amniotic
membranes, and reassuring fetal heart rate (FHR). The
exclusion criteria were multifetal gestation; noncephalic pre-
sentation; premature rupture of membranes; suspicious or
ominous nonstress test result at admission; placenta previa;
suspected macrosomia over 4000 g; a history of uterine scar-
ring or pregnancies complicated by evidence of fetal
congenital malformations, gestational diabetes, hypertension,
intrauterin growth retardation, or chronic illness; and any other
contraindication to vaginal delivery. Patients with contraindi-
cation to prostaglandins administration (allergy, severe
asthma, or pre-existing cardiac or cardiovascular disease),
renal or hepatic dysfunction, and parity > 5 were also
excluded. None of the women in the study received epidural or
other modes of analgesia.
Gestational age was established by the last reported men-
strual period and first-trimester ultrasound measurements.
Ultrasonography was performed on all patients to assess pre-
sentation of fetus, estimated fetal weight, placental site, and
amniotic fluid volume. The amniotic fluid volume was esti-
mated according to the four-quadrant technique.5 The uterus
was divided into four quadrants, by the umbilicus transversely
(into upper and lower halves) and by the linea nigra (into right
and left halves). The maximum vertical diameter of the largestPlease cite this article in press as: Kansu-Celik H, et al., Prostaglandin E2 inductio
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extremities was measured in centimeters. The sum of the
largest vertical pocket in the four quadrants was the AFI. A
depth of 0e5 equated with oligohydramnios.
The dinoprostone insert was left in situ for 12 hours, if
possible, or removed at the onset of active labor. Active labor
was considered to begin when cervical dilatation was 4 cm.6
All cases were followed by continuous electronic fetal moni-
toring. A partogram was drawn to follow the progress of labor.
Artificial rupture of membranes was done at 5-cm dilatation,
and color of amniotic fluid (liquor amnii) was noted. At the
12th hour from the start of treatment, the Bishop scores were
re-evaluated. For patients whose Bishop score was still < 5
(i.e., not exhibiting regular uterine contraction), a vaginal
application of dinoprostone was performed and they were
induced with low-dose oxytocin infusion. Oxytocin augmen-
tation was applied in the second stage, if necessary.
Tachysystole was defined as six or more than five con-
tractions in 10 minutes, averaged over a 30-minute window.
Hyperstimulation was described as a tachysystole with late
FHR decelerations or fetal tachycardia (> 160 beats/min) or
other worrying FHR changes.7 In the event of hyperstimula-
tion, the vaginal dinoprostone insert was removed, and fetal
resuscitation (and tocolysis, if needed) was done. Non-
reassuring FHR patterns were defined as persistent or recur-
ring episodes of severe variable decelerations, late de-
celerations, prolonged fetal bradycardia, or a combination of
decreased beat-to-beat variability and a decelerative pattern.
Demographic and antenatal data were collected from the
delivery chart, computerized data, and patient files. The pri-
mary outcome measures were time from induction to delivery
and incidence of vaginal delivery; the secondary outcomes
were the caesarean section (CS) rate, side effects, rate of failed
induction, the incidence of admission to the neonatal intensive
care unit, and neonatal complications.
All statistical analyses were performed using SPSS soft-
ware (version 15; SPSS Inc., Chicago, IL, USA). Continuous
data are expressed as mean (standard deviation) and were
analyzed with two independent-samples tests. Chi-square and
Fisher's exact tests were used for categorical data. The sig-
nificance boundary ( p) was given as 0.05.
3. Results
A total of 148 patients who satisfied the trial criteria were
recruited into the study; of these, 44 patients declined to
participate, and thus 104 patients [patients with oligohy-
dramnios (n¼ 40) and control patients (n¼ 64)] completed
the study (Fig. 1). The demographic variables of the patients in
Groups A and B are presented in Table 1; age, parity, and
Bishop scores were insignificant between the groups ( p > 0.05
for all). Gestational age was significantly different between the
groups ( p¼ 0.001).
Table 2 summarizes the obstetric and neonatal outcomes.
The mean time intervals from induction to delivery were
21.76± 4.49 hours and 20.86± 4.04 hours for the oligohy-
dramnios and control groups, respectively ( p > 0.05). CS raten of labor and cervical ripening for term isolated oligohydramnios in pregnant
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148 patients enrolled
44 patients declined to participate
104 patients completed the study
All patients received 
dinoprostone vaginally
40 patients with oligohydramnios 64 patients with normal amniotic 
fluid volume
Fig. 1. Flowchart of study profile.
Table 2
Cervical ripening, labor, delivery, and neonatal outcomes of patients.
Oligohydramnios
(n¼ 40, 38%)
Control group
(n¼ 64, 62%)
p
Interval to delivery (h) 21.76± 4.49 20.86± 4.04 NS
No. of success with 21 (52.5) 35 (54.6) NS
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15.6% for the oligohydramnios and the control groups,
respectively ( p¼ 0.005). Hyperstimulation occurred in four of
40 patients in the oligohydramnios group and in one of 64
patients in the control group, without reaching statistically
significant difference.
Of the patients in Groups A and B, 7.5% (3/40) and 3.1%
(2/64), respectively, needed admission to neonatal intensive
care unit within 24 hours after delivery ( p > 0.05). There was
no statistically significant difference in the 5th-minute Apgar
score and postpartum hemorrhage between the groups
( p> 0.05). There were no uterine ruptures, infectious com-
plications, or other major maternal complications.Table 1
Demographic characteristics.
Oligohydramnios
(n¼ 40, 38%)
Control group
(n¼ 64, 62%)
p
Age (years) 25.55± 5.2 25.75± 5.3 NS
Gestational age (wk) 39.8± 1.03 40.7± 0.78 0.001*
Parity 1 (0e5) 1 (0e4) NS
Nulliparous 25 (62.5) 37 (57.8) NS
Bishop score 3.40± 0.6 3.53± 0.6 NS
0e2 6 (15) 8 (12.5) NS
3e5 34 (85) 56 (87.5) NS
Labor induction for
Oligohydramnios 40 (100) 0
Post-term pregnancy 13 (32.5) 38 (59.3)
Suspected fetal surveillance 0 15 (23.4)
Social reasons 0 11 (17.1)
Data are presented as n (%) or mean± standard deviation.
* p< 0.05, significant.
NS ¼ nonsignificant.
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Our study regarding the efficacy and safety of dinoprostone
for cervical ripening and labor induction in term pregnancies
with a Bishop score 5 between patients with isolated oli-
gohydramnios and normal amniotic fluid revealed that dino-
prostone did not decrease the mean time interval from12 h of priming
No. of success with
24 h of priming
29 (72.5) 50 (78.1) NS
Use of oxytocin 9 (22.5) 17 (26.5) NS
Vaginal delivery 24 (60) 54 (84.3) NS
Caesarean delivery for, n (%) 16 (40) 10 (15.6) 0.005*
Fetal distress 8 (50) 3 (30)
Cephalopelvic disproportion 5 (37.5) 4 (40)
Failed induction 3 (12.5) 3 (30)
Uterine tacysystole 4 (10) 2 (3.1) NS
Neonatal birth weight (g) 3256
(2410e4210)
3370
(2650e3990)
NS
Apgar score at the 5th min NS
<7 3 (7.5) 2 (3.1)
Neonatal intensive care
unit admission
3 (7.5) 2 (3.1) NS
Postpartum hemorrhage
(500 mL)
1 (2.5) 2 (3.2) NS
Data are presented as n (%) or mean± standard deviation.
* p< 0.05, significant.
NS ¼ nonsignificant.
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CS in patients with oligohydramnios was higher than in those
with normal amniotic fluid.
Induction of labor is a widely used procedure for various
maternal and fetal indications, one ofwhich is oligohydramnios.
In many cases, the cervixmay not be ripened enough, especially
in primigravidas. Therefore, there is a need to prepare the cervix
for a likely vaginal birth. Various techniques have been used for
this purpose, with vaginal dinoprostone administration being
one of the most commonly used methods of all.8 In this pro-
spective study, dinoprostone administered by the standard once-
daily regimen demonstrated a significantly higher rate of labor
success within 24 hours in the oligohydramnios and control
groups (72% vs. 78%), and the rate of oxytocin use was similar
in both groups. Venturini et al9 and Stefos et al10 studied dino-
prostone gel action vaginally and concluded that it was nonef-
fective in lessening the duration of labor. The primary outcomes
of our study also supported the previous results.
Classically, oligohydramnios has been related to increased
neonatal mortality andmorbidity in high-risk pregnancy status.11
However, some investigators have found an association between
an active induction of labor in term low-risk pregnancy with
isolated oligohydramnios and an increased rate of cesarean sec-
tion without causing any detrimental neonatal outcomes, when
compared with normal AFI.12e16 A meta-analysis done by
Chauchan et al17indicated that there was no association between
olygohydramnios and neonatal acidosis, even though acidosis
resulted in AFI< 5 with an increased risk of CS due to fetal
distress and lower Apgar score. However, this analysis involved
high-risk and preterm pregnancies. Some retrospective studies of
term pregnancies with isolated oligohydramnios reported no
differences inApgar score, requirement of neonatal intensive care
unit, fetal acidosis, or perinatal death from normal AFI preg-
nancieswith induction of labor.12,18,19 Similarly,wealso found an
increased rate of cesarean section in patients with oligohy-
dramnios without an increase in adverse perinatal outcomes. By
contrast, in a retrospective study by Danon et al,20 patients with
uncomplicated oligohydramnios at term underwent induction of
labor with prostaglandin E2; the investigators concluded that the
induction of labor for oligohydramnioswas anovertreatment, and
proposed close surveillance to lower the rate of CS.
Dinoprostone has been administered either vaginally or
intracervically, rather successfully and without serious side
effects in normal pregnancies.13 The most important adverse
reaction of dinoprostone is uterine hyperstimulation. The
incidence of uterine hyperstimulation ranged from 5% to 16%
in patients treated with controlled-release dinoprostone.21 This
condition generally resolves within 15 minutes after removal
of the insert, and patients experiencing hyperstimulation gave
birth to healthy babies without requiring a CS. Car-
diotocogrophic abnormalities are monitored in 3e10% of
women receiving dinoprostone; most of these abnormalities
also resolve quickly after insert removal.21 With regard to
dinoprostone administration and uterine hyperstimulation
frequency, results of our study are similar to others.
In conclusion, a single dose (10 mg) of controlled-release
dinoprostone administered vaginally appears to be a safe forPlease cite this article in press as: Kansu-Celik H, et al., Prostaglandin E2 inductio
women with Bishop score  5, Journal of the Chinese Medical Association (201induction of labor in patients with oligohydramnios. Increased
rates of CS is the detrimental effect of dinoprostone but it does
not have a negative impact on neonatal outcomes. Prospective,
randomized controlled clinical trials with large numbers of
patients are needed to compare dinoprostone in term preg-
nancies with isolated oligohydramnios.References
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